Hedge Fund Drops Million: Beam Biotech Bet Right Now
A major hedge fund just plowed a substantial stake into a gene-editing company, signaling conviction in Beam Therapeu...
Knowing when to rebalance your investment portfolio is crucial for success. Learn key timing insights to optimize your financial strategy.
20,317 articlesA major hedge fund just plowed a substantial stake into a gene-editing company, signaling conviction in Beam Therapeu...
A major fund took a $61 million stake in a leading self-storage REIT just as a blockbuster $10.5 billion deal was win...
A little-known small-cap stock is quietly delivering standout performance in 2026. This article breaks down why it ha...
This guide breaks down what to watch in Jackson Financial's 2025 earnings, with practical tips and real-world scenari...
A fresh stake of roughly $4.5 million by a value-focused firm in Workiva raises questions about what comes next for W...
If you're juggling high-interest debt and a growing investment portfolio, you don't have to choose one over the other...
OpenAI CEO Sam Altman says AI could someday run a major company better than its human leadership, a warning that coul...
The FMC stock story has been rough, but a measured, scenario-driven approach can illuminate where the year ahead migh...
Nine U.S. giants now carry market values that exceed the GDPs of most countries. This report breaks down the data, wh...
When a company's CFO sells a chunk of shares, investors want to know what it means. This guide explains the implicati...
In a year of sharp rotation, the Vanguard FTSE DEVELOPED Markets ETF ex US is outperforming the S&P 500—yet the decad...
Itron stock is making big moves this week, with investors buzzing about quarterly results and smart-city demand. This...